Tadahisa Sugiura

https://assets.montefioreeinstein.org/profiles/images/physphoto/Sugiura_Tadahisa_MD_420x504.jpg

First Name

Tadahisa

Last Name

Sugiura

NPI

1942704267

Faculty ID

16309

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Dr. Sugiura&rsquo;s clinical focus is in structural heart disease, coronary artery bypass surgery, the treatment of end-stage heart failure, extracorporeal membrane oxygenation (ECMO), and cardiothoracic organ procurement.<quillbot-extension-portal></quillbot-extension-portal>

Research Focus

Dr. Sugiura&rsquo;s research focuses on cardiac regenerative therapy, induced pluripotent stem cell (iPS cell) research and stem cell medicine.<quillbot-extension-portal></quillbot-extension-portal>

Elsevier Profile

PubMed.gov URL

EMR ID

14130

Biography

<p>Tadahisa Sugiura, MD, PhD, is an attending surgeon and Assistant Professor at Montefiore-Einstein. Dr. Sugiura&rsquo;s clinical focus is in structural heart disease, coronary artery bypass surgery, the treatment of end-stage heart failure, extracorporeal membrane oxygenation (ECMO), and cardiothoracic organ procurement.</p><p>Educated in Japan, Dr. Sugiura attended University of Tsukuba School of Medicine from 1997 to 2003, earning his Doctor of Medicine degree. He began his postdoctoral training with a residency at Tokyo Women&rsquo;s Medical University from 2003 to 2005, followed by a residency at Seirei Hamamatsu General Hospital in Japan from 2005 to 2007. He then undertook a fellowship at Tokyo Women&rsquo;s Medical University in 2008, followed by a fellowship at Yokohama City University Medical Center from 2009 to 2011. In 2012, he earned his PhD from Tokyo Women&rsquo;s Medical University. Dr. Sugiura came to the United States in 2013 and continued his training, completing a research fellowship at Nationwide Children's Hospital, The Ohio State University in 2016. He was an advanced fellow at Texas Heart Institute at Baylor St. Luke&rsquo;s Medical Center from 2016 to 2018 and a super fellow at Montefiore-Einstein from 2018 to 2019.</p><p>Dr. Sugiura&rsquo;s research focuses on cardiac regenerative therapy, induced pluripotent stem cell (iPS cell) research and stem cell medicine. He has shared his research through publication in many peer-reviewed journals as well as book chapters, abstracts, posters and presentations. He is also an ad hoc reviewer for several publications including <em>The Annals of Thoracic Surgery and Internal Medicine</em>.</p><p>Dr. Sugiura is board certified and is a member of several professional societies.</p>

Is Open Scheduling

Off

Robert E. Michler

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/4c095d20-b884-11ee-946e-1f574f05546e.jpg

First Name

Robert

Last Name

Michler

NPI

1841370491

Faculty ID

10023

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p><a title="View Robert Michler's Montefiore profile" href="https://montefioreeinstein.org/profiles/1841370491/robert-e-michler&quot; target="_blank">Robert E. Michler, MD</a>, has served as the Surgeon-in-Chief of the Montefiore Medical Center since 2008. He is Chairman of the Department of Surgery (2007) and Chairman of the Department of Cardiothoracic &amp; Vascular Surgery (2005) at the Montefiore Medical Center. Dr. Michler holds the Samuel I. Belkin Chair and is Professor with Tenure at the Albert Einstein College of Medicine.</p>
<p>Dr. Michler is an internationally renowned <a title="View Montefiore's heart and surgical service" href="https://montefioreeinstein.org/heart/services/procedures-interventions&…; target="_blank">cardiothoracic surgeon</a> and researcher. He is a highly sought after surgeon and known leader in several surgical specialties, including complex multiprocedural cardiac surgery, mitral and aortic <a title="View Montefiore's heart valve disease and treatment" href="https://montefioreeinstein.org/heart/conditions/heart-valve-diseases&qu…; target="_blank">valve repair surgery</a>, surgery for congestive heart failure, minimally invasive cardiac surgery, and <a title="View Montefiore's hear transplantation" href="https://montefioreeinstein.org/heart/services/programs-centers/cardiolo…; target="_blank">heart transplantation</a>. Of particular note, Dr. Michler was one of the first to perform <a title="View Montefiore's minimally invasive and robot surgery" href="https://montefioreeinstein.org/heart/conditions/heart-valve-diseases&qu…; target="_blank">minimally invasive and robotic surgery</a> in heart patients. His pivotal work in robotics led to Food and Drug Administration (FDA) approval of this advanced technology for <a title="View Montefiore's mitral valve repair" href="https://montefioreeinstein.org/heart/conditions/heart-valve-diseases/mi…; target="_blank">mitral valve repair</a> and coronary artery bypass surgery.</p>
<p>He is an NIH-funded investigator, serving as Principal Investigator for the NIH/NHLBI-sponsored Cardiothoracic Surgical Clinical Trials Network. He has participated in over 50 clinical trials including the use of myoblasts and stem cells for heart failure.</p>
<p>In 2017, Dr. Michler received the Vladimir Borakovsky Prize from the Russian Ministry of Health in Moscow for &ldquo;his personal contributions to the development of cardiovascular surgery&rdquo;.</p>
<p>Dr. Michler lectures extensively, both nationally and abroad, and is a regular Expert Opinion author on heart related topics including stem cell therapies, ischemic mitral regurgitation and ischemic heart failure. Over the years, Dr. Michler has provided regular commentary to NBC Nightly News, the New York Times and the Wall Street Journal.</p>
<p>In his unique role as Chairman of both the Department of Surgery and the Department of Cardiothoracic &amp; Vascular Surgery, Dr. Michler applies his dynamic leadership to expand Montefiore-Einstein's role at the forefront of surgical innovation. In 2017, he was responsible for establishing the Lung and Heart-Lung transplantation and end stage pulmonary failure program at Montefiore-Einstein.</p>
<p>Formerly, Dr. Michler held the John G. and Jeanne Bonnet McCoy Endowed Chair, tenured Professor of Surgery, Chief of Cardiothoracic Surgery and Director of Heart &amp; Lung Transplantation at The Ohio State University Medical Center. He also served as the Associate Director of the Dorothy M. Davis Heart and Lung Research Institute. Dr. Michler was integral to the planning, design, and philanthropic development for the Richard M. Ross Heart Hospital. Dr. Michler served as the first Executive Director of the Richard M. Ross Heart Hospital.</p>
<p>Before joining The Ohio State University faculty, Dr. Michler was a tenured Associate Professor of Surgery at Columbia University and Director of the Heart Transplant Program at Columbia-Presbyterian Medical Center.</p>
<p>Dr. Michler received his undergraduate education <em>Magna Cum Laude</em> from Harvard University. He received his medical education at Dartmouth Medical School where he was a Leopold Schepp Scholar. Dr. Michler completed his residency in General Surgery, a fellowship in Cardiothoracic Transplantation and a fellowship in Cardiothoracic Surgery at the Columbia Presbyterian Medical Center in New York, followed by a fellowship in Pediatric Cardiothoracic Surgery at Boston Children's Hospital, Harvard Medical School.</p>
<p>Dr. Michler has received numerous honors including &ldquo;Person of the Week&rdquo; by ABC World News Tonight, the Pace Humanitarian Award, and &ldquo;The Order of Christopher Columbus&rdquo; by Hippolito Mejia, President of the Dominican Republic.</p>

Specialties

Expert Tags

Areas of Expertise

Expert Summary

<p class="MsoNormal" style="line-height: 15.6pt;"><span style="font-size: 9.0pt;">Dr. Michler is a heart surgeon who specializes in complex aortic and mitral valve repair surgery. He is an NIH-funded investigator whose interest in repairing the injured heart has led to clinical trials in cardiac stem cell transplantation. Dr. Michler and his teams have advanced minimally invasive cardiothoracic surgery procedures and surgical robotics. This work led to FDA approval for selective cardiac robotic procedures including mitral valve repair and coronary bypass surgery.</span></p>
<p class="MsoNormal" style="line-height: 15.6pt;"><span style="font-size: 9.0pt;">Dr. Michler has authored hundreds of peer-reviewed publications, including in the <em>New England Journal of Medicine</em>,<span>&nbsp;</span><em>Circulation</em><span>&nbsp;</span>and the<span>&nbsp;</span><em>Proceedings of the National Academy of Sciences</em>. He is a frequent editor on cardiac surgery topics and lectures extensively, both nationally and abroad. Dr. Michler is the chairman and founder of a not-for-profit foundation, Heart Care International, which performs pediatric heart surgery in underserved regions of the world. To date, Heart Care International has helped over 1,000 children with heart disease and performed heart surgery on over 600 children. He has received numerous honors including &ldquo;Person of the Week&rdquo; by ABC&rsquo;s<span>&nbsp;</span><em>World News Tonight</em><span>&nbsp;</span>and the Order of Christopher Columbus.</span></p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Coronary Artery Bypass Surgery, Heart Failure Surgery, Heart Transplantation, Minimally Invasive Cardiothoracic Surgery, Surgical Ventricular Reconstruction, Valve Repair Surgery

Research Focus

Dr. Michler and his cardiothoracic surgery team are advancing the use of minimally invasive cardiothoracic surgery procedures including coronary bypass, aortic and mitral valve repair procedures, autologous myoblast and stem cell injection therapy.

Elsevier Profile

Selected Publications

<p>Williams JB, Peterson ED, Brennan JM, Sedrakyan A, Tavris D, Alexander JH, Lopes RD, Dokholyan RS, Zhao Y, O&rsquo;Brien SM, <strong>Michler RE</strong>, Thourani VH, Edwards FH, Gross T, Marinac-Dabic D, Smith PK. Endoscopic Association between endoscopic vs open vein-graft harvesting and mortality, wound complications, and cardiovascular events in patients undergoing CABG surgery. JAMA. 2012;308(5):475-84.</p>
<p><strong>Michler RE</strong>, Rouleau JL, Al-Khalidi HR, Bonow RO, Pellikka PA, Pohost GM, Holly TA, Oh JK, Dagenais F, Milano C, Wrobel K, Pirk J, Ali IS, Velazquez EJ, Lee KL, Di Donato M. Insights from the STICH trial: Change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstruction. J Thorac Cardiovasc Surg. 2013;146(5):1139-1145.</p>
<p><strong>Michler RE</strong>. Surgical Options for the Management of Ischemic Cardiomyopathy.Current Treatment Options in Cardiovascular Medicine. 2013;15(5):518-532.</p>
<p>Acker MA, Parides MK, Perrault LP, Moskowitz AJ, Gelijns AC, Voisine P, Smith PK, Hung JW, Blackstone EH, Puskas JD, Argenziano M, Gammie JS, Mack M, Ascheim DD, Bagiella E, Moquete EG, Ferguson TB, Horvath KA, Geller NL, Miller MA, Woo YJ, D'Alessandro DA, Ailawadi G, Dagenais F, Gardner TJ, O'Gara PT, <strong>Michler RE</strong>, Kron IL; the CTSN Mitral-Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation. N Engl J Med. 2014;370(1):23-32.</p>
<p><strong>Michler RE</strong>. Stem cell therapy for heart failure. Cardiol Rev. 2014;22(3):105-16.</p>
<p>Smith PK, Puskas JD, Ascheim DD, Voisine P, Gelijns AC, Moskowitz AJ, Hung JW, Parides MK, Ailawadi G, Perrault LP, Acker MA, Argenziano M, Thourani V, Gammie JS, Miller MA, Pag&eacute; P, Overbey JR, Bagiella E, Dagenais F, Blackstone EH, Kron IL, Goldstein DJ, Rose EA, Moquete EG, Jeffries N, Gardner TJ, O'Gara PT, Alexander JH, <strong>Michler RE</strong>; Cardiothoracic Surgical Trials Network Investigators. Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med. 2014;371(23):2178-88.</p>
<p>&nbsp;</p>

EMR ID

4690

Biography

<p>Robert E. Michler, MD, has served as the Surgeon-in-Chief of the Montefiore Medical Center since 2008. He is Chairman of the Department of Surgery (2007) and Chairman of the Department of Cardiothoracic & Vascular Surgery (2005) at the Montefiore Medical Center. Dr. Michler holds the Samuel I. Belkin Chair and is Professor with Tenure at the Albert Einstein College of Medicine.</p><p>Dr. Michler is an internationally renowned <a href="https://www.montefiore.org/heart-surgical-services">cardiothoracic surgeon</a> and researcher. He is a highly sought after surgeon and known leader in several surgical specialties, including complex multi-procedural cardiac surgery, mitral and aortic <a href="https://www.montefiore.org/heart-valve-repair-and-valve-sparing-surgery… repair surgery</a>, surgery for congestive heart failure, minimally invasive cardiac surgery, and <a href="https://www.montefiore.org/heart-transplant">heart transplantation</a>. Of particular note, Dr. Michler was one of the first to perform <a href="https://www.montefiore.org/minimally-invasive-and-robotic-cardiothoraci… invasive and robotic surgery</a> in heart patients. His pivotal work in robotics led to Food and Drug Administration (FDA) approval of this advanced technology for <a href="https://www.montefiore.org/mitral-valve-repair-and-replacement">mitral valve repair</a> and coronary artery bypass surgery.</p><p>He is an NIH-funded investigator, serving as Principal Investigator for the NIH/NHLBI-sponsored Cardiothoracic Surgical Clinical Trials Network. He has participated in over 50 clinical trials including the use of myoblasts and stem cells for heart failure.</p><p>In 2017, Dr. Michler received the Vladimir Borakovsky Prize from the Russian Ministry of Health in Moscow for &ldquo;his personal contributions to the development of cardiovascular surgery&rdquo;.</p><p>Dr. Michler lectures extensively, both nationally and abroad, and is a regular Expert Opinion author on heart related topics including stem cell therapies, ischemic mitral regurgitation and ischemic heart failure. Over the years, Dr. Michler has provided regular commentary to NBC Nightly News, the New York Times and the Wall Street Journal.</p><p>In his unique role as Chairman of both the Department of Surgery and the Department of Cardiothoracic & Vascular Surgery, Dr. Michler applies his dynamic leadership to expand Montefiore Einstein's role at the forefront of surgical innovation. In 2017, he was responsible for establishing the Lung and Heart-Lung transplantation and end stage pulmonary failure program at Montefiore Einstein.</p><p>Formerly, Dr. Michler held the John G. and Jeanne Bonnet McCoy Endowed Chair, tenured Professor of Surgery, Chief of Cardiothoracic Surgery and Director of Heart & Lung Transplantation at The Ohio State University Medical Center. He also served as the Associate Director of the Dorothy M. Davis Heart and Lung Research Institute. Dr. Michler was integral to the planning, design, and philanthropic development for the Richard M. Ross Heart Hospital. Dr. Michler served as the first Executive Director of the Richard M. Ross Heart Hospital.</p><p>Before joining The Ohio State University faculty, Dr. Michler was a tenured Associate Professor of Surgery at Columbia University and Director of the Heart Transplant Program at Columbia-Presbyterian Medical Center.</p><p>Dr. Michler received his undergraduate education Magna Cum Laude from Harvard University. He received his medical education at Dartmouth Medical School where he was a Leopold Schepp Scholar. Dr. Michler completed his residency in General Surgery, a fellowship in Cardiothoracic Transplantation and a fellowship in Cardiothoracic Surgery at the Columbia Presbyterian Medical Center in New York, followed by a fellowship in Pediatric Cardiothoracic Surgery at Boston Children's Hospital, Harvard Medical School.</p><p>Dr. Michler has received numerous honors including &ldquo;Person of the Week&rdquo; by ABC World News Tonight, the Pace Humanitarian Award, and &ldquo;The Order of Christopher Columbus&rdquo; by Hippolito Mejia, President of the Dominican Republic.</p>

Is Open Scheduling

Off